Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience

BACKGROUND: Despite not being licensed for the treatment of infantile hemangiomas (IH) in infants younger than 5 weeks or older than 5 months, propranolol is often used in these age groups to prevent or to treat potentially severe complications. The objective of the present study was to review the e...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hachem, Maya, Gesualdo, Francesco, Diociaiuti, Andrea, Berti, Irene, Vercellino, Nadia, Boccaletti, Valeria, Neri, Iria, Porcedda, Giulio, Greco, Antonella, Carnevale, Claudia, Oranges, Teresa, Cutrone, Mario, Dalmonte, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395924/
https://www.ncbi.nlm.nih.gov/pubmed/28424095
http://dx.doi.org/10.1186/s13052-017-0357-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395924/
https://www.ncbi.nlm.nih.gov/pubmed/28424095
http://dx.doi.org/10.1186/s13052-017-0357-9

Ejemplares similares